Regeneron Pharmaceuticals Inc. buy Morgan Stanley
Start price
02.06.25
/
50%
€428.20
Target price
02.06.26
€664.02
Performance (%)
17.63%
Price
09:56
€502.80
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley currently has a performance of 17.63%. A total of €0.88 was paid as dividends for this prediction. This prediction currently runs until 02.06.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.739% | 3.739% |
| iShares Core DAX® | -0.560% | -3.108% |
| iShares Nasdaq 100 | 1.622% | 4.701% |
| iShares Nikkei 225® | 1.807% | 5.094% |
| iShares S&P 500 | 0.859% | 2.906% |
Comments by Morgan_Stanley for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at Morgan Stanley from $958.00 to $755.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by Morgan_Stanley for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€479.90
10.07.25
10.07.25
€642.11
10.07.26
10.07.26
4.96%
09:56
09:56
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€779.00
01.11.24
01.11.24
€1,092.0
01.11.25
01.11.25
-35.12%
09:56
09:56
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€995.00
11.07.24
11.07.24
€1,087.6
11.07.25
11.07.25
-51.07%
12.07.25
12.07.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€883.50
18.03.24
18.03.24
€1,025.4
18.03.25
18.03.25
-30.96%
19.03.25
19.03.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€764.50
03.11.23
03.11.23
€854.04
03.11.24
03.11.24
1.87%
04.11.24
04.11.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€785.00
11.10.23
11.10.23
€861.38
11.10.24
11.10.24
17.78%
12.10.24
12.10.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€692.50
04.08.23
04.08.23
€828.28
04.08.24
04.08.24
42.96%
05.08.24
05.08.24